Form 3 - Initial statement of beneficial ownership of securities
10 Luglio 2024 - 11:00PM
Edgar (US Regulatory)
Exhibit 24
POWER OF ATTORNEY
KNOW
ALL BY THESE PRESENTS, that the undersigned hereby constitutes and appoints each of David Meeker, M.D., Jim Flaherty, Hunter
Smith and Christopher German signing singly, as his true and lawful attorney-in-fact to:
(1) execute for and on behalf
of the undersigned, in the undersigned’s capacity as a director of Rhythm Pharmaceuticals, Inc. (the “Company”),
Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder and
any other forms or reports the undersigned may be required to file in connection with the undersigned’s ownership, acquisition,
or disposition of securities of the Company;
(2) do and perform any and all
acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5,
or other form or report, and timely file such form or report with the U.S. Securities and Exchange Commission and any stock exchange
or similar authority; and
(3) take any other action of any
type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest
of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the
undersigned, pursuant to this Power of Attorney, shall be in such form and shall contain such terms and conditions as such attorney-in-fact
may approve in his discretion.
The undersigned hereby grants
to each such attorney-in-fact full power and authority to do and perform each and every act and thing whatsoever requisite, necessary,
and proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned
might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or his substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the
rights and powers herein granted. The undersigned acknowledges that no such attorney-in-fact, in serving in such capacity at the request
of the undersigned, is hereby assuming any of the undersigned’s responsibilities to comply with Section 13 and Section 16
of the Securities Exchange Act of 1934 and the rules thereunder, as amended.
This Power of Attorney shall remain in full force
and effect until revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.
IN
WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 14th day of June,
2024.
|
/s/ Alastair Garfield |
|
Alastair Garfield |
Grafico Azioni Rhythm Pharmaceuticals (NASDAQ:RYTM)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Rhythm Pharmaceuticals (NASDAQ:RYTM)
Storico
Da Gen 2024 a Gen 2025